文献速递脑血管病外科神经重症

丙泊酚激发试验联合术中神经电生理监测在脑动静脉畸形栓塞术中的应用

Pharmacologic Provocative Testing in Combination With Intraoperative Neurophysiologic Monitoring During Arteriovenous Malformation Embolization.
PubMed 文献 · World Neurosurg · 2021-06-30

本研究前瞻性纳入22例脑动静脉畸形患者,在全身麻醉下进行111次丙泊酚激发试验和48次栓塞术,以术中神经电生理监测评估结果。5mg丙泊酚在较大供血动脉中与7mg结果一致,较小血管中3mg与5mg结果一致;激发试验阴性预测值为97.9%(47/48),仅1例阴性后出现术后出血。结论认为该技术有助于预测神经功能缺损并改善手术决策。

要点

  • 丙泊酚激发试验联合IONM可用于全麻下AVM栓塞术中预测神经功能缺损。
  • 较大供血动脉5mg丙泊酚可能足够,较小分支3mg可能足够。
  • 激发试验阴性预测值97.9%,阴性后栓塞术后神经功能缺损风险低。

核心结论

  • 丙泊酚激发试验联合术中神经电生理监测有助于预测神经功能缺损并改善AVM栓塞术中的决策。
  • 较大供血动脉5mg丙泊酚可能足够,较小供血分支3mg可能足够。

研究设计与样本

  • 前瞻性研究,2018年6月1日至2020年6月1日,22例患者在全麻下接受111次丙泊酚激发试验和48次血管内栓塞术。

主要发现

  • 初始48次激发试验中,38次5mg丙泊酚阴性且7mg重复试验也阴性;10次阳性者调整微导管尖端至替代位置直至重复试验阴性。
  • 5mg与7mg丙泊酚激发试验结果在较大供血动脉中一致,3mg与5mg结果在较小血管中一致。
  • 激发试验阴性预测值为97.9%(47/48),48次栓塞中仅1次阴性后出现术后出血,其余47次未导致术后神经功能缺损。

关键数值与推荐

  • 较大供血动脉激发试验使用5mg丙泊酚,较小供血分支使用3mg丙泊酚。
  • 阳性激发试验后调整微导管尖端至替代位置,直至重复试验阴性再行栓塞。

临床怎么用

  • 全麻下AVM栓塞术中可联合丙泊酚激发试验与IONM评估神经功能风险。
  • 根据供血动脉大小选择丙泊酚剂量:较大动脉5mg,较小分支3mg。
  • 阳性激发试验时调整微导管位置直至阴性,以降低术后神经功能缺损风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review our use of pharmacologic provocative testing (PT) and intraoperative neurophysiologic monitoring (IONM) during endovascular embolization for eloquent arteriovenous malformations (AVMs), and better define their clinical utility. METHODS: This is a prospective study between 1 June 2018 and 1 June 2020. Prior to endovascular embolization, superselective PTs with propofol injection were performed. The PT results were assessed by IONM. The impact of different doses of propofol on PT results was compared. RESULTS: Under general anesthesia, 111 PTs and 48 endovascular embolizations were performed in 22 patients. For the initial 48 PTs before planned embolization, 38 PTs with 5 mg propofol were negative and repeat PTs with 7 mg propofol were also negative. For the remaining 10 positive PTs, the microcatheter tip was adjusted to an alternative site until repeat PTs were negative to ensure a subsequent safe embolization. In comparison, 5-mg-propofol PT results were consistent with 7-mg-propofol PTs in larger-sized feeders, whereas for smaller-sized vessels, 3-mg-propofol PT results were consistent with 5-mg-propofol PTs. The negative predictive value of PTs was 97.9% (47 of 48), as only 1 of the 48 embolizations with negative PTs resulted in postoperative hemorrhage and none of the other 47 embolizations led to a postoperative neurologic deficit. CONCLUSIONS: PTs and IONM are valuable techniques to predict neurologic deficits and improve procedure decision-making during AVM embolization under general anesthesia. A 5-mg dose of propofol may be sufficient for PTs in larger-sized feeders and a 3-mg dose may be sufficient in smaller-sized feeding branches.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Tong X, Li X, Ye M, et al. Pharmacologic Provocative Testing in Combination With Intraoperative Neurophysiologic Monitoring During Arteriovenous Malformation Embolization. World Neurosurg. 2021. PMID: 34216836. doi:10.1016/j.wneu.2021.06.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。